HSV-2 spreads through direct skin-to-skin contact during sexual activity, most commonly vaginal, anal, or oral sex with someone who carries the virus. Around 520 million people worldwide have genital HSV-2, and many of them don’t know it, which is a major reason the virus continues to spread so efficiently.
Skin-to-Skin Contact Is the Primary Route
HSV-2 passes from one person to another when the skin or mucous membranes of the genital area come into contact with the virus. This can happen through vaginal sex, anal sex, or oral sex. The virus doesn’t need an open wound or visible sore to transmit. It can enter through the thin, moist tissue that lines the genitals, anus, and mouth, or through tiny breaks in regular skin that you wouldn’t even notice.
You can get HSV-2 from contact with a herpes sore, genital fluids from an infected partner, or simply the skin in the genital area of someone who carries the virus. That last point is important: the virus can be present on skin that looks completely normal.
Why People With No Symptoms Still Transmit
Most HSV-2 transmission happens when the infected person has no visible outbreak. This is because of a process called asymptomatic shedding, where the virus periodically travels to the skin’s surface and becomes contagious without causing any sores or symptoms. Research on men without a prior history of genital herpes found that HSV-2 was present on genital skin about 3% of days overall, with some individuals shedding virus on up to 12.7% of days when no lesions were present.
That might sound like a small number, but over weeks and months of sexual contact with a partner, those days add up. The WHO estimates that at least 42 million people acquire a new genital herpes infection every year, roughly one person every second. A large share of those infections come from partners who had no idea they were contagious at the time.
Who Is More Biologically Vulnerable
Women are more susceptible to acquiring HSV-2 than men. The tissue lining the vagina and cervix provides a larger surface area of thin, delicate mucous membrane where the virus can enter. Research on couples where one partner had HSV-2 and the other didn’t found a striking difference in how well condoms protected each sex: condom use reduced per-act transmission risk from men to women by 96%, but only reduced risk from women to men by about 65%. This gap reflects both anatomical differences and the fact that condoms cover more of the relevant skin surface for male-to-female protection.
Transmission During Pregnancy and Birth
A mother can pass HSV-2 to her baby during vaginal delivery, and the risk depends heavily on timing. If a woman acquires herpes for the first time near the end of pregnancy, transmission rates to the newborn can reach up to 60%. That’s because her body hasn’t yet built antibodies to the virus, so neither she nor the baby has immune protection against it.
For women who had herpes before pregnancy and experience a recurrence near delivery, the risk drops dramatically to less than 2%. Their immune system has already produced antibodies that cross the placenta and offer the baby some passive protection. The viral load during a recurrent outbreak is also much lower than during a first infection.
How Condoms and Antivirals Reduce Risk
Condoms are the most accessible way to lower transmission risk, but they don’t eliminate it entirely. HSV-2 sores and viral shedding can occur on skin that a condom doesn’t cover, like the upper thighs, buttocks, or areas around the genitals. Still, consistent condom use makes a substantial difference, particularly for protecting female partners.
Daily antiviral suppressive therapy cuts the risk roughly in half. In a large clinical trial, couples where the HSV-2 positive partner took a daily antiviral had a transmission rate of 1.9%, compared to 3.6% in couples using a placebo. Combining daily antivirals with consistent condom use provides the strongest protection available outside of abstaining from contact during outbreaks.
What Doesn’t Spread HSV-2
HSV-2 is fragile outside the body. While the virus can technically survive on dry surfaces for a few hours to several weeks depending on humidity and temperature, real-world transmission from objects like toilet seats, towels, or shared utensils is not considered a meaningful risk. The virus requires the kind of direct, sustained skin contact that happens during sex. Casual contact like hugging, handshakes, or sharing food does not spread HSV-2.
Swimming pools, hot tubs, and shared bedding are also not realistic transmission routes. The virus doesn’t survive well in water, and it needs direct mucosal or skin-to-skin contact to establish an infection.
Timeline After Exposure
If you’re exposed to HSV-2 and become infected, symptoms typically appear within six to eight days, though the incubation period can range anywhere from one to 26 days. A first outbreak is usually the most noticeable, often involving clusters of painful blisters or sores in the genital area, sometimes accompanied by flu-like symptoms such as fever, body aches, and swollen lymph nodes. Many people, however, have such mild first episodes that they don’t recognize them as herpes at all.
Blood tests that detect HSV-2 antibodies are not reliable immediately after exposure. It can take up to 16 weeks or more for antibody levels to reach a point where current tests can pick them up. Testing too early can produce a false negative, so timing matters if you’re trying to confirm whether a recent exposure led to infection.
Why So Many Cases Go Unrecognized
A large percentage of people with HSV-2 have never been diagnosed. Some have mild or atypical symptoms they attribute to something else, like an ingrown hair, a yeast infection, or general irritation. Others never develop noticeable symptoms at all but still carry and periodically shed the virus. Standard STI panels typically do not include herpes testing unless you specifically request it or have visible sores, which means many people never learn their status through routine screening. This combination of mild symptoms, irregular shedding, and limited testing is the core reason HSV-2 remains so widespread, affecting more than one in five adults globally.